Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Average (2016 - 2025)

Historic Equity Average for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $27.1 million.

  • Cumberland Pharmaceuticals' Equity Average rose 583.16% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year increase of 583.16%. This contributed to the annual value of $26.2 million for FY2024, which is 2036.24% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Equity Average stood at $27.1 million for Q3 2025, which was up 583.16% from $28.3 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Equity Average registered a high of $47.5 million during Q2 2021, and its lowest value of $23.8 million during Q4 2024.
  • Its 5-year average for Equity Average is $35.5 million, with a median of $36.6 million in 2023.
  • In the last 5 years, Cumberland Pharmaceuticals' Equity Average crashed by 3010.57% in 2024 and then surged by 583.16% in 2025.
  • Cumberland Pharmaceuticals' Equity Average (Quarter) stood at $44.8 million in 2021, then decreased by 16.29% to $37.5 million in 2022, then dropped by 12.58% to $32.8 million in 2023, then fell by 27.38% to $23.8 million in 2024, then grew by 13.6% to $27.1 million in 2025.
  • Its last three reported values are $27.1 million in Q3 2025, $28.3 million for Q2 2025, and $25.8 million during Q1 2025.